1Koski H,Janin A,Humphreys-Beher MG,et al.Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjo-gren's syndrome.Clin Exp Rheumatol,2001,19:131-7.
2Seror R,Ravaud P,Bowman SJ,et al.EULAR Sjogren's syndrome disease activity index:development of a consensus systemic disease activity index for primary Sjogren's syndrome.Ann Rheum Dis,2010,69(6):1103-9.
3Vitali C,Palombi G,Baldini C,et al.Sjogren's syndrome disease damage index and disease activity index; scoring systems for the assessment of disease damage and disease activity in Sjogren's syndrome,derived from an analysis of a cohort of Italian patients.Arthritis Rheum,2007,56(7):2223-2231.
4Bowman SJ,Sutcliffe N,Isenberg DA.et al.Sjogren's systemic clinical activity index (SCAI)-a systemic disease activity measure for use in clinical trials in primary Sjogren' s syndrome.Rheumatology (Oxford),2007,46(12):1845-51.
5Campar A,Isenberg DA.Primary Sjogren's syndrome activity and damage indices comparison.Eur J Clin Invest,2010,40(7):636-644.
6Willeke P,Schotte H,Schluter B,et al.Interleukin lbeta and tumor necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sjogren's syndrome.Ann Rheum Dis,2003,62:359-362.
7Atzeni F,Doria A,Carrabba M,et al.Potential target of inflix-imab in autoimmune and inflammatory diseases.Autoimmun Rev,2007,6(8):529-536.
8Moutsopoulos NM,Katsifis GE,Angelov N,et al.Lack of efficacy of etanercept in Sjogren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.Ann Rheum Dis,2008,67(10):1437-1443.
9Matsukawa A, Yoshimura T, Maeda T, et al. Analysis of the cyto- kine network among tumor necrosis factor alpha, interleukin-lbeta, interleukin-8, and interleukin-1 receptor antagonist in monosodi- um urate crystal-induced rabbit arthritis [J]. Lab Invest, 1998, 78 (5):559-569.
10Di Giovine FS, Malawista SE, Nuki G, et al.Interleukin 1 (IL-I) as a mediator of crystal arthritis. Stimulation of T cell and synovial fi- broblast mitogenesis by urate crystal-induced IL-1 [J].J Immunol, 1987,138(10):3213-3218.
